Humata Health vs MarketAxess

Side-by-side comparison of AI visibility scores, market position, and capabilities

MarketAxess leads in AI visibility (70 vs 34)
Humata Health logo

Humata Health

EmergingDigital Health

Prior Authorization AI (Provider Side)

Raised $25M (Blue Venture Fund, Optum Ventures, Highmark Ventures). 225+ hospitals. ML recommends which clinical documents to include in prior auth submissions, reducing denials before submission.

AI VisibilityBeta
Overall Score
D34
Category Rank
#1 of 1
AI Consensus
66%
Trend
up
Per Platform
ChatGPT
38
Perplexity
45
Gemini
34

About

Humata Health is a prior authorization AI platform serving the provider side of healthcare — helping hospital systems optimize their prior authorization submissions to reduce denial rates before claims are ever sent to payers. The company has raised $25 million from Blue Venture Fund, Optum Ventures, and Highmark Ventures, and is deployed at 225+ hospitals. Founded by an MD, the platform applies ML to recommend the specific clinical documentation that each payer's prior authorization algorithm weights most heavily.

Full profile
MarketAxess logo

MarketAxess

LeaderConsumer Finance

Enterprise

New York electronic bond trading (NASDAQ: MKTX) $763M FY2024 revenue; Open Trading $2T+ liquidity, 40% US IG bond electronification, portfolio trading growth competing with Tradeweb and Bloomberg.

AI VisibilityBeta
Overall Score
B70
Category Rank
#13 of 290
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
65
Perplexity
65
Gemini
68

About

MarketAxess Holdings Inc. is a New York City-based electronic fixed income trading platform — publicly traded on the NASDAQ (NASDAQ: MKTX) as an S&P 500 Financials component — operating the leading electronic trading marketplace for US investment-grade corporate bonds, US high-yield bonds, emerging market bonds, municipal bonds, and US Treasury securities through approximately 850 employees globally. In fiscal year 2024, MarketAxess reported revenues of $763 million with record trading volumes in US investment-grade bonds and emerging market credit, as the multi-year electronification trend in bond markets continued to shift institutional fixed income trading from voice broker-dealer phone execution to electronic all-to-all trading on MarketAxess's Open Trading marketplace. CEO Chris Concannon (joined 2023, formerly Cboe Global Markets president) leads MarketAxess's strategy of expanding market share beyond the institutional investment-grade core into rate products (US Treasuries, agency securities), high-yield, and portfolio trading as fixed income electronification accelerates — currently approximately 40% of US investment-grade bonds trade electronically versus 15% in 2015. MarketAxess's Open Trading protocol (anonymous all-to-all price discovery between buy-side, sell-side, and market makers) generated over $2 trillion in liquidity provision in 2024, reducing transaction costs versus bilateral dealer quotes by an average of $0.28 per $100 face value.

Full profile

AI Visibility Head-to-Head

34
Overall Score
70
#1
Category Rank
#13
66
AI Consensus
79
up
Trend
stable
38
ChatGPT
65
45
Perplexity
65
34
Gemini
68
38
Claude
73
30
Grok
65

Key Details

Category
Prior Authorization AI (Provider Side)
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Humata Health
Prior Authorization AI (Provider Side)
MarketAxess is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.